Y. Kitao

Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode.

M. Asai, T. Inada, G. Yagi, 1996, American journal of medical genetics.

Association between catechol‐O‐methyltransferase (COMT) polymorphism and severe alcoholic withdrawal symptoms in male Japanese alcoholics

T. Inada, Y. Kitao, A. Nakamura, 2001, Addiction biology.

Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.

K. Hashimoto, M. Iyo, T. Inada, 1995, Life Science.

Initial genome‐wide scan for linkage with schizophrenia in the Japanese schizophrenia sib‐pair linkage group (JSSLG) families

S. Tsuji, T. Shinkai, K. Yara, 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

A contribution to genome‐wide association studies: search for susceptibility loci for schizophrenia using DNA microsatellite markers on chromosomes 19, 20, 21 and 22

T. Arinami, T. Inada, C. Hirotsu, 2000, Psychiatric genetics.

Search for a Susceptibility Locus to Tardive Dyskinesia

M. Asai, T. Inada, G. Yagi, 1997 .

Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first‐break schizophrenic patients

M. Asai, T. Inada, G. Yagi, 1995, Psychiatric genetics.

Cytochrome P450 2D6 polymorphism and character traits

Y. Ono, E. Suzuki, T. Inada, 2003, Psychiatric genetics.

The Effects of a Selective cAMP Phosphodiesterase Inhibitor, Rolipram, on Methamphetamine-Induced Behavior

M. Iyo, T. Inada, S. Fukui, 1995, Neuropsychopharmacology.

Effects of a single injection of methamphetamine on central dopaminergic systems in rats with hippocampal lesions

M. Iyo, T. Inada, Y. Kitao, 1996 .

An Exact Test for the Association Between the Disease and Alleles at Highly Polymorphic Loci with Particular Interest in the Haplotype Analysis

T. Inada, C. Hirotsu, C Hirotsu, 2001, Biometrics.